Latest News

December 18, 2013
Experts across UCSF weigh in on what some of 2014's top trends are in research and patient care.
December 18, 2013
Research led by scientists at the UCSF-affiliated Gladstone Institutes has identified the precise chain of molecular events in the human body that drives the death of most of the immune system’s CD4 T cells as an HIV infection leads to AIDS. Further, they have identified an existing anti-inflammatory drug that in laboratory tests blocks the death of these cells.
December 03, 2013
Over more than two decades in Africa, UCSF researchers have approached their scientific work with a dual aim: treat disease while helping to sustainably build up the local health care system.
November 06, 2013
David Baltimore, PhD, will present the 2013 Gladstone Distinguished Lecture on Wednesday, Nov. 20. The lecture, titled, “The Role of MicroRNAs in Immune Functions,” will begin at 4 p.m. in Gladstone’s Robert Mahley Auditorium.
October 01, 2013
UCSF researchers received six of 78 awards announced this week by the National Institutes of Health for innovative, high-risk, high-reward research.
September 04, 2013
A protein at the center of Parkinson’s disease research now also has been found to play a key role in causing the destruction of bacteria that cause tuberculosis.
July 25, 2013
Adenoviruses commonly infect humans, causing colds, flu-like symptoms and sometimes even death, but now UCSF researchers have discovered that a new species of adenovirus can spread from primate to primate, and potentially from monkey to human.
July 19, 2013
UCSF scientists who studied the human body’s response to microgravity have received two out of three awards given by NASA for top International Space Station research in 2012.
June 04, 2013
Investigators at Duke Medicine and UCSF have been selected to oversee a nationwide research program on antibacterial resistance, which will focus on the growing unmet challenges associated with methicillin-resistant Staphylococcus aureus and E. coli.
May 16, 2013
Raising hopes for cell-based therapies, UCSF researchers have created the first functioning human thymus tissue from embryonic stem cells in the laboratory.

Pages